The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Pneumococcal Vaccine: Clinical Efficacy and Effectiveness

[+] Article, Author, and Disclosure Information

Grant support: In part by grant 80304-3H from the John A. Hartford Foundation. Dr. Schwartz is Director, Clinical Efficacy Assessment Project, American College of Physicians; Teaching and Research Scholar, American College of Physicians; and a W.K. Kellogg National Fellow.

▸Requests for reprints should be addressed to J. Sanford Schwartz, M.D., Director; Clinical Efficacy Assessment Project, American College of Physicians, 4200 Pine Street, Philadelphia, PA 19104.

Philadelphia. Pennsylvania

© 1982 American College of PhysiciansAmerican College of Physicians

Ann Intern Med. 1982;96(2):208-220. doi:10.7326/0003-4819-96-2-208
Text Size: A A A

Streptococcus pneumoniae causes substantial morbidity and mortality. Incidence and severity are increased among populations with some chronic diseases. The currently available polyvalent polysaccharide vaccine induces antibody production among immunologically competent recipients against the 14 serotypes responsible for 80% of pneumococcal bacteremia in the United States. The vaccine is safe and has proved efficacious in clinical trials with healthy young men in epidemic conditions and in patients with sickle cell anemia. Similar trials in two other high-risk populations had inconclusive results. Decisions on vaccine use now largely rest on indirect evidence of efficacy derived from knowledge of disease incidence, severity, and antibody response to vaccination among patient groups. Findings of a literature review suggest vaccinating high-risk patients immunologically competent to produce homotypic antibodies in response to vaccination with polysaccharide antigen, while continuing investigation of disease incidence, severity, serotype distribution, and immunologic response among high-risk groups and postmarketing surveillance efforts among all vaccinated patients.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Buy Now for $42.00

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Related Articles
Journal Club
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.